A Jesuit Who Accomplished So Much but Became Now So Little-Known: Joseph de Jouvancy

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

So much to do, so little time.

On October 15, we met to listen to a presentation by Marques Griffin from ChevronTexaco. He gave an overview of the entire oil production process and gave an idea of what types of positions his company had available. We also had this semester’s officer auction, where bidders could hire an officer for an hour to do such as things as cleaning or yard work. Our volleyball tournament to be held on ...

متن کامل

So much effort, so little progress?

In colorectal cancer (CRC), the treatment guidelines differ for Union International Contrè Cancer (UICC) stage II and III colon cancer patients. In patients with stage II colon cancer without risk factors such as T4 tumor, tumor perforation, emergency surgical procedure, or less than 12 removed lymph nodes, the low risk of recurrence is justifying no role of adjuvant chemotherapy. It would be c...

متن کامل

So Much Data, So Little Time

Motivated by the need to cope with floods of data, algorithm design is undergoing profound changes. Self-improvement, online property-preserving filtering, uncertainty, sublinearity and property testing are all parts of the story. I will discuss some of these exciting developments with an emphasis on its geometric aspects.

متن کامل

We Had So Much Fun. Now What?

The declining enrollment is a dilemma that many information systems programs are facing. In this study, we design a “Mobile Star” project to promote the information systems major to high school students in Texas. Each “Mobile Star” project consists of a mobile app development workshop and the student’s app showcase. We expect to explore whether the student’s perceived completion, perceived achi...

متن کامل

Multiple myeloma: so much progress, but so many unsolved questions.

form the results of the first randomized study comparing conventional chemotherapy plus novel agents to tandem high-dose melphalan and ASCT in 402 newly diagnosed MM patients. At the time of the report, with a short follow up, there was no significant difference in OS between the two groups, but PFS was significantly improved in the early HDT arm. Two other ongoing trials, one conducted by the ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Jesuit Studies

سال: 2021

ISSN: ['2214-1324', '2214-1332']

DOI: https://doi.org/10.1163/22141332-0802p009